Dongguan Aohai Technology Co., Ltd. (SHE:002993)

Ligand Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	2,228	1,900	2,536	2,494	1,712	2,022
Short-Term Investments	199.95	103.37	543.77	624.56	-	-
Trading Asset Securities	1,244	1,374	585.7	546.34	1.59	20.16
Cash & Short-Term Investments	3,672	3,377	3,665	3,665	1,714	2,042
Cash Growth	15.35%	-7.86%	-0.00%	113.85%	-16.06%	194.69%
Accounts Receivable	1,826	2,207	1,832	1,229	1,468	1,105
Other Receivables	16.23	134.67	55	49.8	52.86	4.3
Receivables	1,842	2,342	1,887	1,279	1,521	1,109
Inventory	895.06	839.83	779.66	532.88	661.29	356.36
Prepaid Expenses	-	2.29	2.25	1.02	0.28	-
Other Current Assets	163.23	11.46	8.19	7.9	8.33	43.24
Total Current Assets	6,572	6,573	6,343	5,486	3,904	3,551
Property, Plant & Equipment	1,731	1,753	1,316	1,155	835.99	459.7
Long-Term Investments	278.93	287.6	251.76	48.4	9.6	9.6
Goodwill	60.71	60.71	60.71	60.71	3.7	0.56
Other Intangible Assets	131.15	130.82	134.03	133.18	114.37	65.74
Long-Term Deferred Tax Assets	90.42	87.83	70.62	104.95	52	23.5
Long-Term Deferred Charges	44.61	46.8	41.32	32.49	16.14	4.36
Other Long-Term Assets	45.52	33.46	188.44	40.08	124.32	83.26
Total Assets	8,955	8,973	8,406	7,061	5,061	4,197
Accounts Payable	3,050	3,142	2,939	1,924	2,291	1,804
Accrued Expenses	92.12	177.39	156.56	135.54	102.44	84.8
Short-Term Debt	178.9	178.44	104.5	114.13	-	-
Current Portion of Long-Term Debt	-	4	0.8	-	-	-
Current Portion of Leases	95.74	19.86	10.76	15.4	5.45	-
Current Income Taxes Payable	55.21	43.73	36.99	40.39	10.58	16.75
Current Unearned Revenue	47.87	42.1	30.33	37.09	23.52	18.03
Other Current Liabilities	90.88	57.51	60.87	5.69	3.83	2.72
Total Current Liabilities	3,611	3,665	3,340	2,272	2,437	1,926
Long-Term Debt	18.4	92.2	18.6	-	-	-
Long-Term Leases	19.73	21.59	21.95	26.72	12.15	-
Long-Term Unearned Revenue	150.21	152.44	136.16	53.27	49.43	28.54
Long-Term Deferred Tax Liabilities	23.11	21.56	19.3	77.76	59.23	23
Other Long-Term Liabilities	9.67	9.65	8.29	7.58	2.14	3.51
Total Liabilities	3,832	3,963	3,544	2,438	2,559	1,981
Common Stock	276.04	276.04	276.04	276.04	235.04	180.8
Additional Paid-In Capital	2,833	2,830	2,801	2,835	1,211	1,257
Retained Earnings	2,004	1,879	1,745	1,469	1,079	797.29
Treasury Stock	-75.01	-59.38	-40.8	-	-	-
Comprehensive Income & Other	-14.76	-8.38	-8.59	-11.24	-26.37	-18.44
Total Common Equity	5,023	4,917	4,773	4,569	2,499	2,216
Minority Interest	100.33	93.45	87.95	54.18	2.45	0.01
Shareholders' Equity	5,123	5,010	4,861	4,624	2,501	2,216
Total Liabilities & Equity	8,955	8,973	8,406	7,061	5,061	4,197
Total Debt	312.77	316.09	156.61	156.25	17.61	-
Net Cash (Debt)	3,359	3,061	3,509	3,509	1,696	2,042
Net Cash Growth	12.80%	-12.75%	-0.01%	106.86%	-16.92%	199.69%
Net Cash Per Share	12.16	11.06	12.65	14.11	7.20	10.43
Filing Date Shares Outstanding	277.21	273.49	273.2	276.04	235.04	235.04
Total Common Shares Outstanding	277.21	274.66	273.2	276.04	235.04	235.04
Working Capital	2,962	2,907	3,003	3,214	1,468	1,625
Book Value Per Share	18.12	17.90	17.47	16.55	10.63	9.43
Tangible Book Value	4,831	4,725	4,578	4,375	2,381	2,150
Tangible Book Value Per Share	17.43	17.20	16.76	15.85	10.13	9.15
Buildings	-	656.64	577.62	100.66	258.76	207.92
Machinery	-	1,577	1,045	1,016	646.59	323.18
Construction In Progress	-	16.28	29.26	258.44	58.13	15.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.